AmInvestment starts coverage on Feytech with fair value of RM1.32
https://theedgemalaysia.com/node/716080

During the last few days, I was able to find some youtube about FEYTECH. Here are the videos:

Rakuten Trade Ideas Webinar - Feytech Holdings Berhad
https://www.youtube.com/watch?v=0bVs8sMW674

新股上市IPO系列之管理层专访 | FEYTECH
https://www.youtube.com/watch?v=DgbnGyHGt2M

烤問飛達控股｜ CEO 吳柯妮：從上市到全球市場的征途
https://www.youtube.com/watch?v=QYyAdg13N3s

This company already warns that the initial set up cost and marketing cost are high for new clinics and new clinics may require time to attain the patient volume needed for optimal financial outcomes. A few new outlets were opened during February-April 2024.

Therefore, I am afraid this company will remain unprofitable for some time. It has been unprofitable for 3 straight quarters.

According to its IPO prospectus:

3.13 DIVIDEND POLICY
Our Board intends to recommend and distribute dividends of at least 40% of our net profits attributable to the owners of our Company for each financial year.

DC HEALTHCARE GROUP SDN. BERHAD (a substantial shareholder) disposed 28,000,000 shares at 0.200 on 28-May-2024.

DC HEALTHCARE GROUP SDN. BERHAD (a substantial shareholder) disposed 47,872,700 shares at 0.200 on 31-May-2024.

Disposal of ordinary shares by via off market transactions

I am afraid some investors will follow and sell...

There is a blog explaining the unrecognized revenue

The Truth Behind DC Healthcare Results!!
https://klse.i3investor.com/web/blog/detail/faizaleyes/2024-05-27-story-h-160716431-The_Truth_Behind_DC_Healthcare_Results

Contract liabilities

There are 2 Contract liabilities figures in quarterly report. The figure 9,591(000) in the balance sheet as at 31.03.2024 must have included unrecognized revenue in the last quarter and also quarters before that.
as at 31.12.2023 3,709 (000)
as at 31.03.2024 9,591(000)
there is an increase of 5882 (000) from Q4FY2023 to Q1FY2024

This Contract liabilities figure of 5,882 (000) found in the cash flow statement for the first quarter ended 31.03.2024 is the unrecognized revenue generated in the last quarter ALONE.

for Q1FY2024:
total sales = revenue 9,454 (000) + Contract liabilities 5,882 (000) = 15336 (000)

not too bad. This figure is lower than last year Q1FY2023

for Q1FY2023
total sales = revenue 16,811 (000) + Contract liabilities 68 (000) = 16879 (000)

@mudaBubu
is there a way to find out the amount of money customers brought in in the previous quarter (3 months):
amount of money customers brought in and redeemed
amount of money customers brought in and not yet redeemed

we can add these 2 figures to know the amount of money customers brought in

or is there any figure that will help us to know how much revenue (recognized and unrecognized) is generated in previous 3 months.

Thank you in advance!

profit was expected to be lower because of the costs of new outlets and marketing cost. Anyway, revenue was down 44%, now that's a different story. It's horrible!

revenue was down 44% , "mainly due to the lower redemption rate in aesthetic services."

not sure what it means... totally unexpected

the latest QR, net profit 16,882,000

EPS 2.41 sen is based on weighted average number of shares of 699,875,000

EPS 2 sen based on enlarged number of shares of 843.200,000 after IPO.

did not expect it to drop so much...

It is not a disappointing quarterly report for me. Wessex and YES 5G keep disappointing me quarter after quarter that I kind of expect this trend will continue until proven otherwise. The revenue of Wessex increased in last quarter, but net profit was affected by high depreciation. I am more confident about Wessex. YES 5G, well... not so much. Investment is all about future earnings. It is exciting time being YTLPOWER investors.

good results. Already up 3 days, you know Malaysians, it will not surprise me if people sell on news.

as expected, revenue and profit further improve. Last quarter, revenue was 9.3 mil. Its revenue must exceed 10 mil in order to have a profit.

There are some positives:
- the recovery of semiconductor industry is making progress
- new products into the Enterprise Storage market.
- Rest of World sales region (excluding China) grew 53% quarter-over-quarter (q-o-q). Several orders and deliveries were delayed, but not cancelled.

Although China sales is expected to slow in Q3 2024, management is preparing for growth q-o-q. Management is positive but I am going to be conservative and expect revenue and profit to be lower q-o-q. I hope I am wrong. The prospects given by management in previous 2 quarterly report become true. I hope they are right again.

Year-over-year, it should be easy.

Last year figures:
Q3 2023 revenue 3.8 mil, EPS -1.03 sen
Q4 2023 revenue 6.1 mil, EPS -5.73 sen

The figures are low so we should see improvement year-over year for the next 2 quarters Q3 & Q4 2024.

The annual report was out on April 30th, 2024.

Regarding expansion, management noted that:

Opening new clinics generally entails significant initial costs, such as leasing of properties, obtaining medical equipment, recruiting, hiring, training of medical and support staff. Such initial set up costs for new clinics can be a considerable expense before these facilities reach their full operating potential. These expenditures contribute to the challenge of achieving optimal financial performance until the new facilities reach full operational capacity.

... Additionally, the launch of new clinics necessitates robust marketing campaigns to establish a presence in new markets, impacting short-term financial performance. It’s important to note that new clinics may require time to attain the patient volume needed for optimal financial outcomes, leading to thinner margins during the initial phase.

I just read the press release on April 18th.

In 2024, DC Healthcare has expanded its reach by opening four Dr. Chong Clinics located in
- Taman Molek (Johor Bahru) opened in 2024 February
- Bandar Seri Botani (Ipoh) opened in 2024 February
- Auto City (Pulau Pinang) opened in 2024 February
- Publika (Kuala Lumpur) opened in 2024 April

as well as four DC Body outlets in
- Auto City (Pulau Pinang) opened in 2024 February
- USJ Taipan (Selangor) opened in 2024 March
- Publika (Kuala Lumpur) opened in 2024 April
- Bukit Indah (Johor Bahru) opened in 2024 April

With these latest additions, DC Healthcare now operates a total of 17 medical aesthetic clinics and 4 DC Body outlets nationwide

Our member CharlesT shared with us a month ago the following info:

Saw a lot of new names in their latest Annual Report....
4. Naza 5.181%
6. Dali Asia Pacific Fund 1.55%
9. HL Dana Makmur Fund 1.395%
10 HL Growth Fund 1.295%
11.Dali Asia Pacific Fund 1.28%
15.Principal Islamic Smallcap Fund 0.71%
18 HL Foundation Fund 0.518%
19 Principal Islamic Enhance Fund 0.507%
20 HL Foundation Dana 0.482%

Out of 30 top shareholders, at least 17 to 18 r held by Funds

I am sure all these funds and Naza know what they are doing.

AEMULUS usually reports its Q2 quarterly report in May (except FY 2022, which was in April). Based on the prospects given by management in the past 2 quarterly reports, if they become true, investors will see further improvement of revenue and profit

There was an announcement on March 6th, 2024:

Reference is made to the announcement dated 22 December 2023 whereby M&A Securities had on behalf of the Company, announced that the additional listing application for the Proposals and the draft circular to shareholders in relation to the Proposals have been submitted to Bursa Securities for approval on the even date (“Listing Application”).

On behalf of the Board, M&A Securities wishes to announce that the Company has submitted an application to Bursa Securities for the withdrawal of the Listing Application (“Withdrawal Application”).

The decision of the Board was made in order to review the structure of the Proposed Acquisition (and consequently the Proposed Variation). The Board shall make the necessary announcement on the revised proposal in due course.

hope they will review and lower the acquisition price...

I must have accidentally deleted my post:

Prospect (quarterly report released on March 29th, 2024):

Looking ahead, the Group acknowledges the ongoing challenges in the global
semiconductor industry expected to persist into the first half of 2024... A robust and gradual recovery is anticipated in the second half of the financial year 2024.

...

Barring any unforeseen circumstances, the Group maintains an optimistic outlook for
both its business and the industries it operates in, with current signs pointing towards
recovery.

quarterly result improve quarter-to-quarter, maybe the worst is over. Let's wait for the next QR to confirm

I was busy for a month and did not do anything. Just studied a few stocks during public holiday. I was wondering what happened to GCB and thought cocoa bean price must have dropped. To my surprise, it went up further. To me, it is a sell.

at current price, there is much more downside than upside. I would rather sell at this point if I own this share

Cocoa prices are soaring to record levels. What it means for consumers and why ‘the worst is still yet to come’

https://www.cnbc.com/2024/03/26/cocoa-prices-are-soaring-to-record-levels-what-it-means-for-consumers.html?recirc=taboolainternal

RHB is bullish about GCB, Still, they expect lower FY24F-25F earnings

"We factor in higher bean prices, and additional working capital requirements resulting in lower FY24F-25F earnings by 10%."

revenue last QR was 114 mil. Problem was the raw material costs. Anyway, it is still a good start of the year. Good luck to those who own this stock!

is it possible that those who say bad things about this stock are actually the same person, just repeat the same argument and create multiple user IDs?

Did anyone attend the Annual General Meeting (AGM)? Kindly share its future prospect (that is not already covered in quarterly reports)

next quarterly report is most likely announced in the second week of February. Hope to see improvement in revenue & EPS

Can anyone confirm that after Acquisition of Solar Asset & Acquisition of Hydro Asset (more shares to be listed), its EPS 0.03 sen?

volume is lower compared to other IPO during the first day. It is possible that many who get the IPO have not yet sold their shares. Huge supply at 39 sen and above. That is bad for share price. Let's see.

some of the buy queues disappear. It looks like many who get this IPO are still queuing at 39, 39.5 & 40 sen

According to some, it is the best IPO in January. Guess not. Anyway, fundamentally seems nice and I am sure it will go up eventually

how much revenue or EPS after Telekosang Hydro 2 acquisition by JSB? Any analysis?

Coconut, please tell us when you sell!

Is Optimax expanding to Atria shopping mall in Damansara Jaya (Petaling Jaya)? Not open yet, right?

the next few years (until 2027) are not going to be exciting due to growing pains. If I were you, I would sell now and buy back later

Highest revenue in 3 quarters. Looks like the worst is over. Management is also confident about FY2024. Please read its latest quarterly report.

At current price, reward is a lot higher than risk. It has just started to move a bit...

According to TA Research, its core EPS for 9MFY23 was -0.1 sen. For full year FY23 it expects its core EPS to be -0.4 sen. That means TA Research expects Coraza's last quarter is also loss making.

If it does not perform well when it is listed, I am not surprised:

- Its IPO is only oversubscribed by over 16 times
- In the prospectus, it shows that 6-month financial period ended 31 May 2022, the revenue is 105.5 mil; but 6-month financial period ended 31 May 2023 its revenue is only 46 mil. Revenue for FY2022 was 234.6 mil. According to its latest quarterly report Q3FY2023, revenue was only 79 mil for 9 months .

There are no books about investment that will teach us to check Jobstreet comment to decide to buy or not. Jobstreet comment is not important. At the end of the days, it is the earning that counts.

Buy on rumors, sell on news? Let's see...

company is doing ok but its expansion is too slow. It was listed on 2022-4-18. Its IPO proceeds should be used for expansion within 3 years. According to its latest quarterly report, its IPO money is hardly used more than one and half year later.

Just read quarterly report. Looks like the worst is over. No wonder people rush into this stock the last few days. Congratulations! Good choice! You guys are great hunters! I am too slow...

Revenue for FY2023 was 145 mil. According to its latest quarterly report Q1FY2024, revenue was only 22.7 mil. It expects that the orders from some of its existing customers will remain softened for the first half of FYE 30 June 2024 and rebound in the second half of FYE 30 June 2024. Next QR is not going to be exciting as well. Price targets given before QR (reported on November 30th) may need downward adjustment.

This makes its evaluation unattractive at IPO price. Besides, industrial product and technology counters have been down recently.

It will not surprise me if its share price does not perform well during the first day. Let see.

good company but evaluation is too high considering its annual growth. At current price of 88 sen, the risk is higher than reward

SUNZEN is also selling bird nest to China. Its quarterly report seems to be fine. Not sure why MBN''s QR is this bad.

Since the new aluminium can plant in USA is going to be loss making for a few years, maybe it is a good idea to sell now and buy back later.

投资者用脚投票！遇到这种IPO，需要提防管理层另有意图？【谈股论金 132】
https://www.youtube.com/watch?v=8y3nDQonPu4

what happened? bad incoming QR? force selling? margin call?